Open AccessSurgery and radioablation therapy combined: introducing a 1-week-condensed procedure bonding total thyroidectomy and radioablation therapy with recombinant human TSH
Author(s) -
Nikos Emmanouilidis,
Jörg Andreas Müller,
Mark D. Jäger,
Stephan Kaaden,
Fabian Helfritz,
Zeynep Esra Güner,
Holger Kespohl,
Wolfgang Knitsch,
Wolfram H. Knapp,
Jürgen Klempnauer,
Georg F. W. Scheumann
Publication year - 2009
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje-08-0641
Subject(s) - thyroidectomy , medicine , recombinant dna , radiation therapy , radioiodine therapy , surgery , endocrinology , urology , thyroid , chemistry , biochemistry , thyroid cancer , gene
The objective of this study was to determine whether the use of recombinant human TSH (rhTSH) to stimulate radioiodine uptake after thyroidectomy is as efficacious as a period of withholding thyroid hormones, while at the same time avoiding hypothyroidism, reducing sick leave time and shortening the hospital stay.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom